+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biogen Inc. - logo

Founded in 1978 Biogen Inc is a global biotechnology company with its headquarters in Cambridge, Massachusetts. In 2003 Biogen merged with Idec Pharmaceuticals to create Biogen Idec and acquired Syntonix Pharmaceuticals in 2007. In 2015 the company returned to its original name Biogen Inc and acquired Convergence Pharmaceuticals. Biogen focuses on drug discovery for a range of conditions including neuropathic pain, hemophilia, organ failure, neuromuscular disorders and oncology. Their product portfolio includes Rituxan, Avonex, Tecfidera and Eloctate.

Burkholderia Pseudomallei Infections Drug Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Burkholderia Pseudomallei Infections Drug Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • June 2023
  • 74 Pages
  • Global
From
Hemophilia Drugs Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Hemophilia Drugs Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • March 2022
  • 98 Pages
  • Global
From
Idiopathic Pulmonary Fibrosis: Competitive Landscape to 2026 - Product Thumbnail Image

Idiopathic Pulmonary Fibrosis: Competitive Landscape to 2026

  • Report
  • March 2019
  • 47 Pages
  • Global
From
Gene Therapy Market Report and Forecast 2023-2031 - Product Thumbnail Image

Gene Therapy Market Report and Forecast 2023-2031

  • Report
  • May 2023
  • 147 Pages
  • Global
From
Spinal Muscular Atrophy Treatment Market Size, Share & Industry Trends Analysis Report By Type (Type 1, Type 2, Type 3 and Type 4), By Route of Administration, By Treatment Type (Drug and Gene Therapy), By Drug Type, By Regional Outlook and Forecast, 2022 - 2028 - Product Thumbnail Image

Spinal Muscular Atrophy Treatment Market Size, Share & Industry Trends Analysis Report By Type (Type 1, Type 2, Type 3 and Type 4), By Route of Administration, By Treatment Type (Drug and Gene Therapy), By Drug Type, By Regional Outlook and Forecast, 2022 - 2028

  • Report
  • November 2022
  • 252 Pages
  • Global
From
Specialty Pharmaceutical Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Specialty Pharmaceutical Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • May 2023
  • 108 Pages
  • Global
From
Adeno-Associated Virus Vector-Based Gene Therapy Market Report and Forecast 2023-2031 - Product Thumbnail Image

Adeno-Associated Virus Vector-Based Gene Therapy Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
Tyrosine Protein Kinase Btk Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Tyrosine Protein Kinase Btk Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • April 2022
  • 98 Pages
  • Global
From
Arzerra - Product Thumbnail Image

Arzerra

  • Report
  • January 2019
  • 18 Pages
  • Global
From
Recombinant DNA Technology Market Growth Analysis Report - Latest Trends, Driving Factors and Key Players Research to 2030 - Product Thumbnail Image

Recombinant DNA Technology Market Growth Analysis Report - Latest Trends, Driving Factors and Key Players Research to 2030

  • Report
  • October 2023
  • 146 Pages
  • Global
From
Myasthenia Gravis Disease Drug Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Myasthenia Gravis Disease Drug Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • April 2023
  • 116 Pages
  • Global
From
Central Nervous System Therapeutic Global Market Insights 2023, Analysis and Forecast to 2028, by Market Participants, Regions, Technology, Application - Product Thumbnail Image

Central Nervous System Therapeutic Global Market Insights 2023, Analysis and Forecast to 2028, by Market Participants, Regions, Technology, Application

  • Report
  • February 2023
  • 116 Pages
  • Global
From
Cancer Antibody Drug Conjugates Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Cancer Antibody Drug Conjugates Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • July 2023
  • 125 Pages
  • Global
From
Spinocerebellar Ataxia (SCA) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Spinocerebellar Ataxia (SCA) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • September 2022
  • 91 Pages
  • Global
From
United States Biotech Industry Report - Product Thumbnail Image

United States Biotech Industry Report

  • Report
  • May 2023
  • 24 Pages
  • United States
From
Multiple Sclerosis: Dynamic Market Forecast to 2026 - Product Thumbnail Image

Multiple Sclerosis: Dynamic Market Forecast to 2026

  • Report
  • November 2018
  • 53 Pages
  • Global
From
Stroke - Pipeline Review, H2 2020 - Product Thumbnail Image

Stroke - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 773 Pages
  • Global
From
Europe Spinal Muscular Atrophy Treatment Market Size, Share & Industry Trends Analysis Report By Type (Type 1, Type 2, Type 3 and Type 4), By Route of Administration, By Treatment Type (Drug and Gene Therapy), By Drug Type, By Country and Growth Forecast, 2022 - 2028 - Product Thumbnail Image

Europe Spinal Muscular Atrophy Treatment Market Size, Share & Industry Trends Analysis Report By Type (Type 1, Type 2, Type 3 and Type 4), By Route of Administration, By Treatment Type (Drug and Gene Therapy), By Drug Type, By Country and Growth Forecast, 2022 - 2028

  • Report
  • November 2022
  • 98 Pages
  • Europe
From
LAMEA Spinal Muscular Atrophy Treatment Market Size, Share & Industry Trends Analysis Report By Type (Type 1, Type 2, Type 3 and Type 4), By Route of Administration, By Treatment Type (Drug and Gene Therapy), By Drug Type, By Country and Growth Forecast, 2022 - 2028 - Product Thumbnail Image

LAMEA Spinal Muscular Atrophy Treatment Market Size, Share & Industry Trends Analysis Report By Type (Type 1, Type 2, Type 3 and Type 4), By Route of Administration, By Treatment Type (Drug and Gene Therapy), By Drug Type, By Country and Growth Forecast, 2022 - 2028

  • Report
  • November 2022
  • 99 Pages
  • Middle East, Africa
From
Asia Pacific Spinal Muscular Atrophy Treatment Market Size, Share & Industry Trends Analysis Report By Type (Type 1, Type 2, Type 3 and Type 4), By Route of Administration, By Treatment Type (Drug and Gene Therapy), By Drug Type, By Country and Growth Forecast, 2022 - 2028 - Product Thumbnail Image

Asia Pacific Spinal Muscular Atrophy Treatment Market Size, Share & Industry Trends Analysis Report By Type (Type 1, Type 2, Type 3 and Type 4), By Route of Administration, By Treatment Type (Drug and Gene Therapy), By Drug Type, By Country and Growth Forecast, 2022 - 2028

  • Report
  • November 2022
  • 99 Pages
  • Asia Pacific
From
Loading Indicator